Checkpoint Capital as of Dec. 31, 2023
Portfolio Holdings for Checkpoint Capital
Checkpoint Capital holds 18 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals (RYTM) | 20.3 | $34M | 730k | 45.97 | |
| Argenx Se Sponsored Adr (ARGX) | 16.1 | $27M | 70k | 380.43 | |
| Cytokinetics Com New (CYTK) | 11.6 | $19M | 230k | 83.49 | |
| Spdr Biotech Etf Tr Unit Put Option (XBI) | 9.7 | $16M | 180k | 89.29 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 9.6 | $16M | 1.4M | 11.44 | |
| Springworks Therapeutics (SWTX) | 7.5 | $12M | 340k | 36.50 | |
| Axsome Therapeutics (AXSM) | 7.5 | $12M | 155k | 79.59 | |
| Mirum Pharmaceuticals (MIRM) | 4.2 | $6.9M | 234k | 29.52 | |
| Protagonist Therapeutics (PTGX) | 3.7 | $6.1M | 267k | 22.93 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 2.8 | $4.6M | 325k | 14.12 | |
| Phathom Pharmaceuticals (PHAT) | 2.0 | $3.3M | 359k | 9.13 | |
| Atyr Pharma Com New (LIFE) | 1.3 | $2.1M | 1.5M | 1.41 | |
| Trevi Therapeutics (TRVI) | 1.0 | $1.7M | 1.3M | 1.34 | |
| Gh Research Ordinary Shares (GHRS) | 1.0 | $1.7M | 294k | 5.80 | |
| Allakos (ALLK) | 0.7 | $1.2M | 445k | 2.73 | |
| Disc Medicine (IRON) | 0.3 | $578k | 10k | 57.76 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $476k | 454k | 1.05 | |
| Edgewise Therapeutics (EWTX) | 0.2 | $361k | 33k | 10.94 |
